SK Bioscience Co Ltd Capital Reinvestment Ratio
SK Bioscience Co Ltd capital reinvestment ratio. SK Bioscience Co Ltd (302440) has a Capital Reinvestment Ratio of 3.44x as of September 2025, meaning it reinvests 3% of its operating cash flow (₩20.65 Billion) in capital expenditures (₩70.94 Billion). Check how aggressively does SK Bioscience Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of SK Bioscience Co Ltd (2018–2023)
Capital reinvestment ratio of SK Bioscience Co Ltd from 2018 to 2023. This chart tracks SK Bioscience Co Ltd's Capital Reinvestment Ratio across 5 annual periods. Also explore SK Bioscience Co Ltd (302440) equity growth momentum to track the company's year-over-year net asset growth rate.
SK Bioscience Co Ltd Capital Reinvestment Ratio by Year (2018–2023)
SK Bioscience Co Ltd capital reinvestment ratio by year from 2018 to 2023. For the full cash flow conversion analysis, see SK Bioscience Co Ltd cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 1.71x | ₩29.35 Billion | ₩50.30 Billion | ▲ +2043.3% |
| 2021 | 0.08x | ₩536.59 Billion | ₩42.91 Billion | ▼ -3.2% |
| 2020 | 0.08x | ₩120.22 Billion | ₩9.93 Billion | ▼ -92.5% |
| 2019 | 1.10x | ₩21.82 Billion | ₩23.97 Billion | ▲ +159.4% |
| 2018 | 0.42x | ₩14.90 Billion | ₩6.31 Billion | — |